Neonatal candidiasis: diagnosis, prevention, and treatment.

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Journal of Infection

• Publication date

  2014-11-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.jinf.2014.07.012PMID 25129318PMCID PMC4252884
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Empiric antifungal therapy and outcomes in extremely low birth weight infants with invasive candidiasis.

  2012cited by this paper
• Therapeutic Monitoring of Voriconazole in Children Less Than Three Years of Age: A Case Report and Summary of Voriconazole Concentrations for Ten Children

  2012cited by this paper
• β-Glucan antigenemia assay for the diagnosis of invasive fungal infections in patients with hematological malignancies: a systematic review and meta-analysis of cohort studies from the Third European Conference on Infections in Leukemia (ECIL-3).

  2012cited by this paper
• Antifungal Therapy and Outcomes in Infants With Invasive Candida Infections

  2012cited by this paper
• Fluconazole Loading Dose Pharmacokinetics and Safety in Infants

  2011cited by this paper
• Safety and Pharmacokinetics of Multiple‐Dose Anidulafungin in Infants and Neonates

  2011cited by this paper
• Population Pharmacokinetics of Micafungin in Neonates and Young Infants

  2010cited by this paper
• Neonatal Candidiasis: Epidemiology, Risk Factors, and Clinical Judgment

  2010cited by this paper
• Fluconazole Dosing for the Prevention or Treatment of Invasive Candidiasis in Young Infants

  2009influential reference
• Pharmacokinetics of an Elevated Dosage of Micafungin in Premature Neonates

  2009cited by this paper
• Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America.

  2009influential reference
• Pharmacokinetics and Safety of Caspofungin in Neonates and Infants Less than 3 Months of Age

  2008cited by this paper
• The pharmacokinetics and pharmacodynamics of micafungin in experimental hematogenous Candida meningoencephalitis: implications for echinocandin therapy in neonates.

  2008cited by this paper
• Population Pharmacokinetics of Fluconazole in Young Infants

  2008cited by this paper
• 1,3-Beta-D-glucan antigenemia for early diagnosis of invasive fungal infections in neutropenic patients with acute leukemia.

  2008cited by this paper
• Pediatric Antifungal Utilization: New Drugs, New Trends

  2008cited by this paper
• A multicenter, randomized trial of prophylactic fluconazole in preterm neonates.

  2007cited by this paper
• Neonatal Candida meningitis: significance of cerebrospinal fluid parameters and blood cultures

  2007influential reference
• Neonatal Candidiasis Among Extremely Low Birth Weight Infants: Risk Factors, Mortality Rates, and Neurodevelopmental Outcomes at 18 to 22 Months

  2007influential reference
• Neonatal Candidiasis Among Extremely Low Birth Weight Infants: Risk Factors, Mortality Rates, and Neurodevelopmental Outcomes at 18 to 22 Months

  2006cited by this paper
• The Pharmacokinetics and Safety of Micafungin, a Novel Echinocandin, in Premature Infants

  2006cited by this paper
• The Association of Third-Generation Cephalosporin Use and Invasive Candidiasis in Extremely Low Birth-Weight Infants

  2006cited by this paper
• Evidence of excessive concentrations of 5-flucytosine in children aged below 12 years: a 12-year review of serum concentrations from a UK clinical assay reference laboratory.

  2006cited by this paper
• Laboratory diagnosis of invasive candidiasis.

  2005cited by this paper
• Population Pharmacokinetics of Amphotericin B Lipid Complex in Neonates

  2005cited by this paper
• Neonatal candidemia and end-organ damage: a critical appraisal of the literature using meta-analytic techniques.

  2003cited by this paper
• Time to positive culture results in neonatal Candida septicemia.

  2003cited by this paper
• Empirical therapy for neonatal candidemia in very low birth weight infants.

  2003cited by this paper
• Fluconazole prophylaxis against fungal colonization and infection in preterm infants.

  2001cited by this paper
• Treatment of candidal infections with fluconazole in neonates and infants.

  2000cited by this paper
• Risk factors for candidemia in Neonatal Intensive Care Unit patients

  2000cited by this paper
• Simple and Rapid Detection of Candida albicans DNA in Serum by PCR for Diagnosis of Invasive Candidiasis

  2000cited by this paper
• Liposomal Amphotericin B (AmBisome) in the Treatment of Neonatal Candidiasis in Very Low Birth Weight Infants

  2000cited by this paper
• Pharmacokinetics of fluconazole in young infants

  1999cited by this paper
• PCR-Restriction Enzyme Analysis for Detection ofCandida DNA in Blood from Febrile Patients with Hematological Malignancies

  1999cited by this paper
• Lysis-centrifugation blood cultures in the detection of tissue-proven invasive candidiasis. Disseminated versus single-organ infection.

  1993cited by this paper
• Pharmacokinetics, outcome of treatment, and toxic effects of amphotericin B and 5-fluorocytosine in neonates.

  1990cited by this paper
• Laboratory diagnosis of invasive candidiasis

  1990cited by this paper

• Pathogen Profiles and Antimicrobial Resistance Patterns of Neonatal Sepsis in the Gulf Cooperation Council: A Systematic Review

  2025cites this paper
• The Burden of Neonatal Invasive Candidiasis in Low- and Middle-income Countries: A Systematic Review and Meta-analysis

  2025cites this paper
• Clinical features, risk factors, and outcomes of neonatal invasive candidiasis: a 20-case study series from a tertiary neonatal critical care unit in Oman

  2025cites this paper
• Skin Care of Infants Born at 21-23 Weeks' Gestation.

  2025cites this paper
• Neonatal Sepsis: A Comprehensive Review

  2024cites this paper
• Changes in the epidemiology of neonatal bacteremia during the COVID-19 pandemic in Wuhan, China

  2024cites this paper
• Infecciones fúngicas invasivas en el recién nacido prematuro

  2024cites this paper
• Dermatología del prematuro

  2024cites this paper
• Identification of Candida species from blood samples of neonates by PCR-RFLP method in Western U.P

  2024cites this paper
• Congenital Sepsis with Candida albicans—A Rare Event in the Neonatal Period: Report of Two Cases and Literature Review

  2024cites this paper
• Nursing Interventions and Biochemical Markers in Early Detection of Neonatal Sepsis

  2024cites this paper
• Prevalence and Species Distribution of Neonatal Candidiasis: A Systematic Review and Meta-Analysis

  2024cites this paper
• Emergence of rare and uncommon yeast-like pathogens causing neonatal sepsis at a tertiary care center, North India.

  2024cites this paper
• Antibiotic Stewardship in the Neonatal Intensive Care Unit

  2024cites this paper
• Infections fongiques invasives du nouveau-né prématuré

  2024cites this paper
• Human Milk Oligosaccharides: Decoding Their Structural Variability, Health Benefits, and the Evolution of Infant Nutrition

  2024cites this paper
• Antimicrobial Resistance Patterns Among Neonates Referred to Pediatric Emergency in North India: A Prospective Cohort Study

  2023cites this paper
• Infections fongiques en pédiatrie

  2023cites this paper
• [Human milk oligosaccharides play major roles in child development and future health].

  2023cites this paper
• Infecciones fúngicas en pediatría

  2023cites this paper
• The Nonbacterial Microbiome: Fungal and Viral Contributions to the Preterm Infant Gut in Health and Disease

  2023cites this paper
• Evaluation and Management of Main Bacterial Infections in Premature Infants

  2022cites this paper
• Antibodies targeting Candida albicans Als3 and Hyr1 antigens protect neonatal mice from candidiasis

  2022cites this paper
• Current status of antihistamine drugs repurposing for infectious diseases

  2022cites this paper
• Current status of antihistamines repurposing for infectious diseases (preprint)

  2022cites this paper
• Infection prevention for extremely low birth weight infants in the NICU

  2022cites this paper
• The first fungi: mode of delivery determines early life fungal colonization in the intestine of preterm infants

  2022cites this paper
• Gold standard for nutrition: a review of human milk oligosaccharide and its effects on infant gut microbiota

  2021cites this paper
• Candida albicans—The Virulence Factors and Clinical Manifestations of Infection

  2021cites this paper
• A meta-analysis of fluconazole for the prevention of invasive fungal infection in preterm infants.

  2021cites this paper
• Review of Fluconazole Treatment and Prophylaxis for Invasive Candidiasis in Neonates.

  2021cites this paper
• Bacterial Pathogens and Evaluation of a Cut-Off for Defining Early and Late Neonatal Infection

  2021cites this paper
• Candidíase e candidemia neonatal: Revisão de literatura

  2021cites this paper
• Distinct innate immune responses between sublethal and lethal models of disseminated candidiasis in newborn BALB/c mice.

  2021cites this paper
• Evolved to protect, designed to destroy: IL‐17‐producing γδ T cells in infection, inflammation, and cancer

  2021cites this paper
• Invasive candidiasis in a neonatal intensive care unit in Fukuoka.

  2021cites this paper
• Treatment of vulvovaginal candidiasis in preparation programs for in vitro fertilization

  2021cites this paper
• Consensus guidelines for the diagnosis and management of cryptococcosis and rare yeast infections in the haematology/oncology setting, 2021

  2021cites this paper
• The Validity of Positive Coagulase-Negative Staphylococcus Cultures for the Diagnosis of Sepsis in the Neonatal Unit

  2021cites this paper
• The Impact of Rapid Species Identification on Management of Bloodstream Infections: What's in a Name?

  2020cites this paper
• Physiologically-Based Pharmacokinetic Modeling Characterizes the CYP3A-Mediated Drug-Drug Interaction Between Fluconazole and Sildenafil in Infants

  2020cites this paper
• Review of Amphotericin B for Invasive Fungal Infections in Neonates and Children

  2020cites this paper
• NON-ALBICANS SPECIES: MAIN ACTORS OF CANDIDEMIA? SEVEN-YEAR EXPERIENCE FROM A SINGLE CENTRE

  2020cites this paper
• Vesikeln, Pusteln und Vesikulopusteln im frühen Kindesalter

  2020cites this paper
• [Vesicles, pustules and vesicopustules in early childhood].

  2020cites this paper
• Neonatal Oral Colonization with Candida in Jos, North-Central Nigeria

  2020cites this paper
• Neonatal Skin

  2020cites this paper
• Effect of a surveillance system for decreasing neonatal nosocomial infections.

  2019cites this paper
• Prevalence and Antifungal Susceptibility of Candida albicans Causing Vulvovaginitis Among Pregnant Women in Lebanon

  2019cites this paper
• Safety, Effectiveness and Exposure-response of Micafungin in Infants: Application of an Established Pharmacokinetics Model to Electronic Health Records

  2019cites this paper
• Condylomata acuminata and Candida vulvovaginitis during pregnancy – current facts and therapeutic possibilities

  2019cites this paper
• Oral nystatin prophylaxis to prevent systemic fungal infection in very low birth weight preterm infants: a randomized controlled trial

  2019cites this paper
• Invasive Candidiasis in Neonatal Intensive Care Unit

  2019cites this paper
• Antifungal Drugs for Invasive Candida Infections (ICI) in Neonates: Future Perspectives

  2019cites this paper
• Clinical practice update of antifungal prophylaxis in immunocompromised children

  2019cites this paper
• Prophylactic regimens with fluconazole for candidiasis in neonates under 1.500g: A retrospective chart review of two cohorts

  2019cites this paper
• Neonatal sepsis biomarkers: where are we now?

  2019cites this paper
• Maternal pregnancy-induced hypertension increases the subsequent risk of neonatal candidiasis: A nationwide population-based cohort study.

  2019cites this paper
• [Clinical value of droplet digital PCR in rapid diagnosis of invasive fungal infection in neonates].

  2019cites this paper
• Infections of the Skin

  2018cites this paper
• Liver fungal infections: an overview of the etiology and epidemiology in patients affected or not affected by oncohematologic malignancies

  2018cites this paper
• Advances in the Treatment of Mycoses in Pediatric Patients

  2018cites this paper
• Chronic Candidiasis in Children

  2017influential citation
• Evolving Invasive Neonatal Systemic Candidiasis, a Review

  2017influential citation
• Infant fungal communities: current knowledge and research opportunities

  2017cites this paper
• Profile of Superficial Mycoses in Pediatric Dermatology Patient

  2017cites this paper
• Fluconazole prophylaxis in preterm infants: a systematic review

  2017cites this paper
• Skin infections in pregnancy.

  2016cites this paper
• Pharmacodynamic studies of voriconazole: informing the clinical management of invasive fungal infections

  2016cites this paper
• Advances in the treatment of invasive neonatal candidiasis

  2015cites this paper
• Coping with Stress and the Emergence of Multidrug Resistance in Fungi

  2015cites this paper
• Therapeutic strategies for invasive fungal infections in neonatal and pediatric patients: an update

  2015cites this paper
• Identification of Candida species from blood samples of neonates by PCR-RFLP method in Western U.P

  year unknowncites this paper